gentleMACS Octo Dissociator with Heaters

The National Institutes of Health intends to award a Firm-Fixed-Price Purchase Order to Miltenyi Biotec, Inc. for the purchase of the gentleMACS Octo Dissociator with Heaters. This instrument is essential for the laboratories in the Women's Malignancies Branch to support ongoing experimental studies and carry out core laboratory procedures. The instrument enables the generation of viable single-cell suspensions from complex tissues, which is a critical step in the current experimental workflows. • The gentleMACS Octo Dissociator with Heaters is required to maintain cell viability and integrity for downstream applications such as molecular profiling, functional assays, and biomarker analysis. • The instrument will enhance the rigor of the research and accelerate insights into the biology of breast cancer brain metastasis. • Small businesses may submit a written capability statement to demonstrate their ability to perform the requirement.